AN2 Therapeutics Inc (ANTX)

1.41 +0.15 (+11.90%) USD  |  NASDAQ  |  Dec 23, 16:00
1.41 0.00 (0.00%) After-Hours: 20:00
More

AN2 Therapeutics Enterprise Value: -55.78M for Dec. 20, 2024

Enterprise Value Chart

View Enterprise Value for ANTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Biomarin Pharmaceutical Inc 12.18B
Arbutus Biopharma Corp 480.47M
GlycoMimetics Inc 0.6782M
FibroGen Inc 24.05M
Cidara Therapeutics Inc 126.62M

Enterprise Value Related Metrics

Net Income (Quarterly) -12.75M
Total Expenses (Quarterly) 11.77M
EPS Diluted (Quarterly) -0.43
Earnings Yield -144.7%